Oxidative activation of the Ca 2 + /calmodulin-dependent protein kinase II (CaMKII) regulates vascular smooth muscle migration and apoptosis
Abstract Activation of the Ca 2 + /calmodulin-dependent protein kinase II (CaMKII) and reactive oxygen species (ROS) promote neointimal hyperplasia after vascular injury. CaMKII can be directly activated by ROS through oxidation. In this study, we determined whether abolishing the oxidative activati...
Saved in:
Published in | Vascular pharmacology Vol. 60; no. 2; pp. 75 - 83 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Activation of the Ca 2 + /calmodulin-dependent protein kinase II (CaMKII) and reactive oxygen species (ROS) promote neointimal hyperplasia after vascular injury. CaMKII can be directly activated by ROS through oxidation. In this study, we determined whether abolishing the oxidative activation site of CaMKII alters vascular smooth muscle cell (VCMC) proliferation, migration and apoptosis in vitro and neointimal formation in vivo . VSMC isolated from a knock-in mouse with oxidation-resistant CaMKIIδ (CaMKII M2V) displayed similar proliferation but decreased migration and apoptosis. Surprisingly, ROS production and expression of the NADPH oxidase subunits p47 and p22 were decreased in M2V VSMC, whereas superoxide dismutase 2 protein expression was upregulated. In vivo , after carotid artery ligation, no differences in neointimal size or remodeling were observed. In contrast to VSMC, CaMKII expression and autonomous activity were significantly higher in M2V compared to WT carotid arteries, suggesting that an autoregulatory mechanism determines CaMKII activity in vivo . Our findings demonstrate that preventing oxidative activation of CaMKII decreases migration and apoptosis in vitro and suggest that CaMKII regulates ROS production. Our study presents novel evidence that CaMKII expression in vivo is regulated by a negative feedback loop following oxidative activation. |
---|---|
AbstractList | Abstract Activation of the Ca 2 + /calmodulin-dependent protein kinase II (CaMKII) and reactive oxygen species (ROS) promote neointimal hyperplasia after vascular injury. CaMKII can be directly activated by ROS through oxidation. In this study, we determined whether abolishing the oxidative activation site of CaMKII alters vascular smooth muscle cell (VCMC) proliferation, migration and apoptosis in vitro and neointimal formation in vivo . VSMC isolated from a knock-in mouse with oxidation-resistant CaMKIIδ (CaMKII M2V) displayed similar proliferation but decreased migration and apoptosis. Surprisingly, ROS production and expression of the NADPH oxidase subunits p47 and p22 were decreased in M2V VSMC, whereas superoxide dismutase 2 protein expression was upregulated. In vivo , after carotid artery ligation, no differences in neointimal size or remodeling were observed. In contrast to VSMC, CaMKII expression and autonomous activity were significantly higher in M2V compared to WT carotid arteries, suggesting that an autoregulatory mechanism determines CaMKII activity in vivo . Our findings demonstrate that preventing oxidative activation of CaMKII decreases migration and apoptosis in vitro and suggest that CaMKII regulates ROS production. Our study presents novel evidence that CaMKII expression in vivo is regulated by a negative feedback loop following oxidative activation. |
Author | Luczak, Elizabeth D Zhu, Linda J Venema, Ashlee N Xie, Litao Scott, Jason A Prasad, Anand M Grumbach, Isabella M Dibbern, Megan E Nguyen, Emily K Klutho, Paula J Jaffer, Omar A Anderson, Mark E Guan, Xiaoqun |
Author_xml | – sequence: 1 fullname: Zhu, Linda J – sequence: 2 fullname: Klutho, Paula J – sequence: 3 fullname: Scott, Jason A – sequence: 4 fullname: Xie, Litao – sequence: 5 fullname: Luczak, Elizabeth D – sequence: 6 fullname: Dibbern, Megan E – sequence: 7 fullname: Prasad, Anand M – sequence: 8 fullname: Jaffer, Omar A – sequence: 9 fullname: Venema, Ashlee N – sequence: 10 fullname: Nguyen, Emily K – sequence: 11 fullname: Guan, Xiaoqun – sequence: 12 fullname: Anderson, Mark E – sequence: 13 fullname: Grumbach, Isabella M |
BookMark | eNqlT0FOwzAQ9KFItMADuO0RhJLaaSnphUsEaoQQB7hbq2TbOE3syOtE8AcejSv4AXuZmdVqZ2YhZtZZEuJayVRJtVm26TQ0aSbVOpUqlVLNxFzdrx4SlW_VuVgwt3GZ55vtXHy_fZoag5kIsIoQqbPg9hAaggIhgztYVtj1rh47Y5OaBrI12QCDd4GMhaOxyARlCTcFvr6U5S14OowdBmKYkKtIPXDvXGigH7nqCHpz8L9OaGvAwQ3BseFLcbbHjunqDy_E4_PTR7FLKIrJkNdVzGBinCN9Ebdu9DbeaaU501K_n0qeOqq1jJPJ1b8f_ADJ920N |
ContentType | Journal Article |
DOI | 10.1016/j.vph.2014.01.001 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EndPage | 83 |
ExternalDocumentID | 1_s2_0_S1537189114000020 |
GroupedDBID | --- --K --M -RU .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAXKI AAXUO ABBQC ABFRF ABJNI ABMAC ABMZM ABXDB ABZDS ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OA~ OGGZJ OL0 OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SDF SDG SDP SES SEW SPCBC SSH SSP SSZ T5K UHS UNMZH Z5R ~G- |
ID | FETCH-elsevier_clinicalkeyesjournals_1_s2_0_S15371891140000203 |
ISSN | 1537-1891 |
IngestDate | Tue Oct 15 22:57:18 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Reactive oxygen species CaMKII Migration Proliferation Apoptosis |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-elsevier_clinicalkeyesjournals_1_s2_0_S15371891140000203 |
ParticipantIDs | elsevier_clinicalkeyesjournals_1_s2_0_S1537189114000020 |
PublicationCentury | 2000 |
PublicationDate | 2014 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – year: 2014 text: 2014 |
PublicationDecade | 2010 |
PublicationTitle | Vascular pharmacology |
PublicationYear | 2014 |
SSID | ssj0018869 |
Score | 4.147956 |
Snippet | Abstract Activation of the Ca 2 + /calmodulin-dependent protein kinase II (CaMKII) and reactive oxygen species (ROS) promote neointimal hyperplasia after... |
SourceID | elsevier |
SourceType | Publisher |
StartPage | 75 |
SubjectTerms | Cardiovascular |
Title | Oxidative activation of the Ca 2 + /calmodulin-dependent protein kinase II (CaMKII) regulates vascular smooth muscle migration and apoptosis |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S1537189114000020 |
Volume | 60 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbK9sILgg3EXecBTaAspU7TzX1BYtWmZdVg0rqp4iWyG4cF1KSa0wl44Bfwg_h5HMexm7EijT4kinJ18n2xj8-VkFdCct5LhfBDJpkfCkr9vpzgVkdySoXspamOHT7-sHN4Fh6Ne-NW63fDa2leivbkx9K4klVQxX2Iq46S_Q9k3U1xB24jvrhGhHF9K4w_fssSk7hbhydcOelPC5MD7gWI6x4uB4jDtEi0z7lvi96WXpWhIcu9r1mOI5kXRZVBlx8Po0irCi5NkXqpPOesqqYF4upN5wrb4U2zzzV7qnyvs2JWFipTTWn33F45WyTIdir8TxdzpxRYGKeG-L0uCuuz2DhwOqldS464LproiDeuS0VnJS-aKgwTNOr6212fMlOwy3bIpsBATbyg0buaGit2nO4uHQGMMuJL-2qmTU00rJKy1vqSa9m29wdD6qug3fFPdSt0I3CyWZlmr59s5kqxCuJOfOPUO2Q9wC5OO5O2fzrnIspYVUzRvZ61p1eehX81rSEGNUSb0X1yr56TwHtDsAekJfMNsnViMPu-DaNFjJ7ahi04aaC5SX45FsKChVCkgCyEAYcAPHi7jIFQMxAMAyGK4LXh3xtw7APLPjDsA8M-cOwDZB849j0k7w72R4ND375rbEN_cbCSqv6rVPyvD919RNbyIpePCXQZF6LPeJ-yJKQJ52mvm-JMV9Kks9Nn4ROyu-JDnq585TNyV0NqlHPPyVp5OZcvUFwtxcuKGX8Aeq6bzA |
link.rule.ids | 315,783,787,4031,27935,27936,27937 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oxidative+activation+of+the+Ca+2+%2B+%2Fcalmodulin-dependent+protein+kinase+II+%28CaMKII%29+regulates+vascular+smooth+muscle+migration+and+apoptosis&rft.jtitle=Vascular+pharmacology&rft.au=Zhu%2C+Linda+J&rft.au=Klutho%2C+Paula+J&rft.au=Scott%2C+Jason+A&rft.au=Xie%2C+Litao&rft.date=2014&rft.issn=1537-1891&rft.volume=60&rft.issue=2&rft.spage=75&rft.epage=83&rft_id=info:doi/10.1016%2Fj.vph.2014.01.001&rft.externalDBID=ECK1-s2.0-S1537189114000020&rft.externalDocID=1_s2_0_S1537189114000020 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15371891%2FS1537189114X00030%2Fcov150h.gif |